1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 to 75 Sponsor: Other Protocol IDs: 9267-01, 2001-034, NCT00221702
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A6181065, NCT00267748
|
|
3.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: YALE-HIC-27409, 7317, NCI-7317, NCT00217542
|
|
4.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: METRO1/IPC2005-001, NCT00908869
|
|
5.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: EPROST-20070805, SCCC-2007055, NCT00854581
|